Attrition rate and its predictors among adults receiving anti-retroviral therapy following the implementation of the “Universal Test and Treat strategy” at public health institutions in Northern Ethiopia. A retrospective follow-up study

[1]  M. Chimbari,et al.  Factors Influencing Rapid Antiretroviral Therapy Initiation at Four eThekwini Clinics, KwaZulu-Natal, South Africa , 2021, AIDS and Behavior.

[2]  J. Eaton,et al.  Incidence and predictors of attrition among patients receiving ART in eastern Zimbabwe before, and after the introduction of universal ‘treat-all’ policies: A competing risk analysis , 2021, PLOS global public health.

[3]  M. Fox,et al.  Attrition in HIV care following HIV diagnosis: a comparison of the pre‐UTT and UTT eras in South Africa , 2021, Journal of the International AIDS Society.

[4]  L. Lynen,et al.  Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV “Treat All” in Zimbabwe , 2020, PloS one.

[5]  C. T. Leshargie,et al.  Incidence and predictors of loss to follow-up among HIV-positive adults in northwest Ethiopia: a retrospective cohort study , 2020, Tropical Medicine and Health.

[6]  A. Wensing,et al.  Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries , 2020 .

[7]  D. J. Joseph Davey,et al.  Same‐day antiretroviral therapy is associated with increased loss to follow‐up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV , 2020, Journal of the International AIDS Society.

[8]  A. Wensing,et al.  Risk factors for loss to follow-up from antiretroviral therapy programmes in low- and middle-income countries: a systematic review and meta-analysis. , 2020, AIDS.

[9]  N. Kiwanuka,et al.  Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda , 2020, PloS one.

[10]  W. Cahyati,et al.  Socio-demographic Factors Associated with Loss to Follow up Anti Retro Viral Therapy among People Living with HIV and AIDS in Semarang City , 2020 .

[11]  Hsin-Yun Sun,et al.  Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan , 2019, BMJ Open.

[12]  L. Lynen,et al.  Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015 , 2019, bioRxiv.

[13]  N. Kiwanuka,et al.  Starting antiretroviral therapy within seven days of a positive HIV test increased the risk of loss to follow up in a primary healthcare clinic: a retrospective cohort study in Masaka, Uganda , 2019, bioRxiv.

[14]  A. Amberbir,et al.  Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study , 2019, Journal of the International AIDS Society.

[15]  M. Petersen,et al.  Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis , 2019, PloS one.

[16]  Wubareg Seifu,et al.  Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study , 2018, BMC Infectious Diseases.

[17]  T. Le.  World Health Organization Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy , 2018 .

[18]  K. K. K. Htet,et al.  Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for ‘test and treat’? , 2018, Global health action.

[19]  Patrick S Olsen,et al.  Improving retention in HIV care among adolescents and adults in low- and middle-income countries: A systematic review of the literature , 2017, PloS one.

[20]  M. Mirra,et al.  Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, Ethiopia , 2017, BMJ Global Health.

[21]  M. Couvillon,et al.  Outcomes of HIV‐positive patients lost to follow‐up in African treatment programmes , 2017, Tropical medicine & international health : TM & IH.

[22]  H. Hatano,et al.  The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting , 2017, Journal of acquired immune deficiency syndromes.

[23]  M. Petersen,et al.  High levels of retention in care with streamlined care and universal test and treat in East Africa , 2016, AIDS.

[24]  L. Atuyambe,et al.  Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda , 2015, BMC Infectious Diseases.

[25]  M. Cappellini,et al.  Anemia in Clinical Practice-Definition and Classification: Does Hemoglobin Change With Aging? , 2015, Seminars in hematology.

[26]  S. Rosen,et al.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008–2013 , 2015, Journal of acquired immune deficiency syndromes.

[27]  A. Westfall,et al.  Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention , 2012, Journal of acquired immune deficiency syndromes.

[28]  E. N. Waddell,et al.  Social Support, Disclosure, and Use of Antiretroviral Therapy , 2006, AIDS and Behavior.

[29]  B. Ootim,et al.  Social Support , 1986, Ageing and Society.